A randomized placebo-controlled trial of the efficacy of denosumab in Indian postmenopausal women with osteoporosis

Consistent with results from studies conducted in other parts of the world, denosumab was well tolerated and effective in increasing BMD and decreasing bone turnover markers over a six-month period in Indian postmenopausal women.